CPT® Code 86945

1. Indications

The irradiation of blood products, as described by CPT® Code 86945, is indicated for specific patient populations and clinical scenarios. The following conditions warrant the use of this procedure:

• Immunocompromised Patients Patients with weakened immune systems, such as those undergoing chemotherapy, organ transplant recipients, or individuals with certain autoimmune disorders, may require irradiated blood to prevent transfusion-related complications.
• Multiple Transfusion Recipients Individuals who have received multiple blood transfusions are at an increased risk for developing transfusion-associated graft-versus-host disease (TA-GvHD). Irradiation helps mitigate this risk.
• Neonates Newborns, particularly premature infants or those with low birth weight, may be at risk for TA-GvHD and are often given irradiated blood products to enhance safety.

2. Procedure

The procedure for irradiating blood products involves several critical steps to ensure the effective treatment of each unit of blood. The following outlines the procedural steps:

• Step 1: Preparation of Blood Product The blood product, typically collected from a donor, is prepared for irradiation. This involves ensuring that the unit is properly labeled and that all necessary documentation is in place to track the blood product throughout the process.
• Step 2: Irradiation Process The prepared unit of blood is then placed in an irradiation device. This device emits a specific dose of radiation, which is calibrated to effectively neutralize lymphocytes while preserving the integrity of the blood components. The irradiation is performed according to established protocols to ensure safety and efficacy.
• Step 3: Post-Irradiation Handling After irradiation, the blood product is carefully monitored and stored under appropriate conditions to maintain its viability. It is essential to document the irradiation process, including the date, time, and dose of radiation administered, as part of the blood product's traceability.

3. Post-Procedure

Following the irradiation of the blood product, there are specific considerations for post-procedure care. The irradiated blood must be stored in a controlled environment to ensure its safety and effectiveness until it is transfused. Healthcare providers should monitor the blood product for any signs of contamination or degradation. Additionally, proper documentation of the irradiation process is crucial for compliance and traceability. When the irradiated blood is transfused to the patient, healthcare professionals should continue to observe the patient for any adverse reactions, although the risk is significantly reduced due to the irradiation process.